The Food and Drug Administration has been mired in controversies related to drug approvals and COVID-19 vaccines, all without a permanent leader. It’s a tough job in normal times, observers say, and at the moment might be the worst top job in Washington.
Rachana Pradhan
Posted inHealth & Wellness
‘We sent a terrible message’: Scientists say Biden jumped the gun with vaccine booster plan
Many experts say the evidence doesn’t justify widespread booster shots for adults. “We just sent a message out there that people who consider themselves fully vaccinated were not fully vaccinated,” one doctor said. “And that’s the wrong message, because you are protected against serious illness.”
Posted inVaccine Watch
Unused Johnson & Johnson doses are piling up as FDA waits to see if shelf life can be extended
As vaccine expiration dates loom, states with hundreds of thousands of doses on hand say demand is tanking and there’s no easy way to donate to other states or countries that might want them
Posted inVaccine Watch
CVS and Walgreens have wasted more vaccine doses than most states combined
More than 200,000 doses of covid vaccine have gone to waste since December, KHN has learned. Two national pharmacy chains account for most of it.
Posted inCOVID 2022
Have a case of a COVID variant? No one is going to tell you
As experts race to get an approved test for covid variants, officials are severely restricted from sharing information about the cases. That makes it harder to protect others.
Posted inVaccine Watch
After billions of dollars and dozens of wartime declarations, why are vaccines still in short supply?
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.